Clinical trial
Clinical Trial to Test the Efficacy and Safety of MMFS-205 in Early Alzheimer's Disease Patients
NCT03531684 is registered in ClinicalTrials.gov with Neurocentria, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial to Test the Efficacy and Safety of MMFS-205 in Early Alzheimer's Disease Patients
- Lead sponsor
- Neurocentria, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 20, 2018
- Completion date
- April 22, 2020
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.